A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors

Clinical trial NCT06258408 · RECRUITING

Trial details

NCT number: NCT06258408
Sponsor: Broadenbio Ltd., Co.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-12-29
Primary completion: 2026-12-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.